Why the study?
The study was conducted to analyse the improvement of adherence after using multicompartment compliance aids in non-adherent, polymedicated patients older than 55 years with uncontrolled hypertension.
Do multicompartment compliance aids improve blood pressure values in polymedicated, non-adherent patients older than 55 years with uncontrolled hypertension?
Do multicompartment compliance aids improve blood pressure values in polymedicated, non-adherent patients older than 55 years with uncontrolled hypertension?
The use of multicompartment compliance aids significantly reduces systolic blood pressure in older, polymedicated, non-adherent patients with uncontrolled hypertension.
May support MCA for SBP control in nonadherent elderly hypertensives; hypothesis-generating and requires RCT confirmation before practice change.
Objectives: To analyse the improvement of adherence in non-adherent patients with uncontrolled HT, polymedicated and older than 55 years after the use, or not, of Multicompartment compliance aids (MCA). Design: Longitudinal research (6 month). Levels of adherence to treatment were analysed using an adapted version of Morisky-Green test, counting of returned medication (MCA group) and blood pressure (BP) values. Site: Multicentre study in 35 community pharmacies in Spain. Participants: 195 participants (88 MCA group and 107 control group) older than 55 years, polymedicated, non-adherent to medication, with uncontrolled hypertension and using electronic prescription. Interventions: MCA group received their medication in MCA while control group received their medication as usual. Main measurements: Systolic BP/Diastolic BP was recurrently measured with a digital tensiometer in both groups. Results: MCA group obtained a significant decrease in BP values compared to the control group (Systolic BP decreased by 18.3 mmHg in the MCA group vs. 9.9 mmHg in the control group and Diastolic BP by 9.9 mmHg vs. 8.9 mmHg). Both groups increased their adherence to over 90%. Conclusions: The use of MCA controlled BP levels in almost 50% of the participants. For this fact, MCA is postulated as a good tool (cost-effective, well tolerated by users, easy to use ...) to improve the adherence of patients and control their hypertension, although more studies are necessary.
No takes yet. Share an insight, caveat, or question.
Oliveros et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: